KERALA AYURVEDA LIMITED Financials Kerala Ayurveda Limited
Equities
KERALAYUR6
INE817B01025
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 293.2 INR | -0.48% |
|
-0.66% | +9.93% |
| Jan. 04 | Kerala Ayurveda Limited announced that it has received INR 212.00963 million in funding | CI |
| 2023 | Kerala Ayurveda Limited announced a financing transaction | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 888.3 | 705.1 | 386.3 | 542 | 824.9 | 880.1 |
| Enterprise Value (EV) 1 | 1,573 | 1,320 | 964.6 | 1,131 | 1,496 | 1,573 |
| P/E ratio | 31.6 x | 28.8 x | 9.91 x | -11.2 x | 35.1 x | -97.7 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.59 x | 1.13 x | 0.5 x | 0.87 x | 1.03 x | 0.94 x |
| EV / Revenue | 2.82 x | 2.12 x | 1.26 x | 1.82 x | 1.86 x | 1.68 x |
| EV / EBITDA | 18.6 x | 28.6 x | 12.1 x | 52.6 x | 13.9 x | 27.2 x |
| EV / FCF | -9.87 x | 9.85 x | 60.4 x | 46.4 x | -36.2 x | 825 x |
| FCF Yield | -10.1% | 10.2% | 1.65% | 2.15% | -2.77% | 0.12% |
| Price to Book | 11.2 x | 18.9 x | 4.87 x | 15.9 x | 13.5 x | 15.8 x |
| Nbr of stocks (in thousands) | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 | 10,556 |
| Reference price 2 | 84.15 | 66.80 | 36.60 | 51.35 | 78.15 | 83.38 |
| Announcement Date | 10/31/18 | 9/1/19 | 9/10/20 | 9/8/21 | 9/6/22 | 9/6/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 557.9 | 621.9 | 767.7 | 621.5 | 803.5 | 936.2 |
| EBITDA 1 | 84.43 | 46.12 | 79.9 | 21.51 | 107.5 | 57.88 |
| EBIT 1 | 67.13 | 37.37 | 69.73 | 8.734 | 97.19 | 48.46 |
| Operating Margin | 12.03% | 6.01% | 9.08% | 1.41% | 12.1% | 5.18% |
| Earnings before Tax (EBT) 1 | 41.66 | 30.98 | 45.38 | -67.38 | 28.05 | -5.59 |
| Net income 1 | 28.08 | 24.45 | 38.97 | -48.44 | 23.62 | -9.005 |
| Net margin | 5.03% | 3.93% | 5.08% | -7.79% | 2.94% | -0.96% |
| EPS 2 | 2.660 | 2.316 | 3.692 | -4.589 | 2.228 | -0.8531 |
| Free Cash Flow 1 | -159.4 | 134 | 15.96 | 24.37 | -41.36 | 1.905 |
| FCF margin | -28.57% | 21.55% | 2.08% | 3.92% | -5.15% | 0.2% |
| FCF Conversion (EBITDA) | - | 290.63% | 19.97% | 113.27% | - | 3.29% |
| FCF Conversion (Net income) | - | 548.31% | 40.94% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 10/31/18 | 9/1/19 | 9/10/20 | 9/8/21 | 9/6/22 | 9/6/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 685 | 615 | 578 | 589 | 671 | 692 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 8.108 x | 13.33 x | 7.237 x | 27.39 x | 6.237 x | 11.96 x |
| Free Cash Flow 1 | -159 | 134 | 16 | 24.4 | -41.4 | 1.91 |
| ROE (net income / shareholders' equity) | 32.1% | 34% | 53.7% | -64.9% | 36.4% | -5.41% |
| ROA (Net income/ Total Assets) | 4.57% | 2.39% | 4.46% | 0.5% | 5.41% | 2.69% |
| Assets 1 | 614.1 | 1,022 | 873 | -9,649 | 436.9 | -334.6 |
| Book Value Per Share 2 | 7.490 | 3.530 | 7.510 | 3.220 | 5.790 | 5.280 |
| Cash Flow per Share 2 | 6.370 | 4.310 | 6.030 | 17.60 | 2.650 | 3.030 |
| Capex 1 | 54.9 | 24.6 | 33.5 | 10.4 | 28.5 | 61.8 |
| Capex / Sales | 9.84% | 3.96% | 4.36% | 1.68% | 3.55% | 6.6% |
| Announcement Date | 10/31/18 | 9/1/19 | 9/10/20 | 9/8/21 | 9/6/22 | 9/6/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +9.93% | 42.57M | |
| -15.58% | 1.35B |
- Stock Market
- Equities
- KERALAYUR6 Stock
- Financials Kerala Ayurveda Limited
